Paving the way to improve therapy for Myeloproliferative Neoplasms
Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergise with IFNα by targeting stem cell function or feedback loops that media...
Main Authors: | Megan Bywater, Steven W. Lane |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-32694-2 |
Similar Items
-
Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues
by: Marie Hautin, et al.
Published: (2020-08-01) -
Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019-07-01) -
Myeloproliferative neoplasms
by: Jean-Jacques Kiladjian
Published: (2018-06-01) -
Myeloproliferative neoplasms
by: Nick Cross, (Coordinating Author)
Published: (2019-06-01) -
The microenvironment in myeloproliferative neoplasm
by: Simón Méndez-Ferrer, et al.
Published: (2018-06-01)